Meyers Michael L.

CIK 00016642042 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001664204

Recent Transactions

24 trades

Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2025-06-18+4,147→ 4,147 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2025-06-18+2,647→ 5,146 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2024-06-12+3,789→ 3,789 total
Award
Nuvalent, Inc.$NUVL
Class A Common Stock
2024-06-12+2,499→ 2,499 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2023-06-15+15,000→ 15,000 total
Award
Nuvalent, Inc.$NUVL
Stock Option (Right to Buy)
2022-10-04+40,000→ 40,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2022-02-02$15.79/sh+17,350→ 17,350 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-01-31$12.39/sh+1,714→ 23,280 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-12-30$8.77/sh+5,900→ 21,566 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-12-30−5,900→ 0 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-04-26$15.46/sh+500→ 15,666 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2021-02-03+80,000→ 80,000 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-01-31$12.00/sh+1,771→ 15,166 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-07-31$7.97/sh+2,665→ 13,395 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2020-07-06+3,500→ 10,730 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-02-12+50,825→ 50,825 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2019-03-21$4.87/sh+8→ 7,230 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2019-03-21$4.93/sh+1,000→ 7,118 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2019-03-21$4.87/sh+104→ 7,222 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2019-02-06+104,325→ 104,325 total
Other
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2019-01-31$4.76/sh+3,720→ 6,118 total
Purchase
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2018-10-30$4.79/sh+200→ 2,398 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-03-01+75,000→ 75,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-02-06+66,100→ 66,100 total

Companies

Recent Filings

Address

C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov